![](https://www.biopharmadive.com/imgproxy/rbUIxL2fteu0CWPor5pBeSw5or18GSQ2YWkAEJMOHVE/g:ce/rs:fit:770:435/bG9jYWw6Ly8vZGl2ZWltYWdlL0dldHR5SW1hZ2VzLTEyMTUxNzg0MDVfb2hpc1M1Yy5qcGc=.webp)
Novo’s once-weekly insulin rejected by FDA
Dive Brief: The Food and Drug Administration rejected Novo Nordisk’s application to sell a once-weekly insulin treatment called icodec, sending the Danish drugmaker a series of requests related to manufacturing and its potential use in Type 1 diabetes. …